Zhao Yulong, Bijlsma Elisabeth Y, Verdouw Monika P, Groenink Lucianne
Division of Pharmacology, UIPS (Utrecht Institute of Pharmaceutical Sciences), Universiteitsweg 99, 3584 CG Utrecht, Netherlands.
Division of Pharmacology, UIPS (Utrecht Institute of Pharmaceutical Sciences), Universiteitsweg 99, 3584 CG Utrecht, Netherlands.
Behav Brain Res. 2018 Oct 1;351:24-33. doi: 10.1016/j.bbr.2018.05.022. Epub 2018 May 24.
The prevalence of anxiety disorders is higher in women than in men. Yet preclinical studies on anxiety are mostly performed in male subjects. This may have limited our understanding of mechanisms contributing to anxiety disorders. Since fear conditioning is considered an important factor in the etiology of anxiety disorders, the present study aimed to investigate the effect of sex and estrous cycle on conditioned fear and the anxiolytic effect of benzodiazepines in rats. We measured the fear-potentiated startle response in male and female rats during different estrous cycle stages and performed a replication study in a separate cohort. In addition, we assessed the response to diazepam (0-3.0 mg/kg IP) and chlordiazepoxide (0-10 mg/kg IP) in male and female rats in proestrous/estrous and diestrous stage. Our results showed that there were no sex differences in the expression of fear-potentiated startle. The estrous cycle also did not affect the fear-potentiated startle response. In addition, male and female rats did not differ in their fear-potentiated startle response following treatment with either diazepam or chlordiazepoxide. In conclusion, the current study shows that male and female rats do not differ in their conditioned fear response and the responsiveness to benzodiazepines. The results further indicate that conditioned fear-related processes are not affected by gonadal hormone fluctuations in this paradigm. These findings may suggest that the higher prevalence of anxiety disorders in women more likely results from differences in responding to previous experiences or differences in other predisposing factors, rather than differences in conditioned fear per se.
焦虑症在女性中的患病率高于男性。然而,关于焦虑的临床前研究大多在雄性受试者中进行。这可能限制了我们对导致焦虑症机制的理解。由于恐惧条件反射被认为是焦虑症病因中的一个重要因素,本研究旨在探讨性别和发情周期对条件性恐惧的影响以及苯二氮䓬类药物对大鼠的抗焦虑作用。我们在不同发情周期阶段测量了雄性和雌性大鼠的恐惧增强惊吓反应,并在另一个队列中进行了重复研究。此外,我们评估了处于动情前期/发情期和动情间期的雄性和雌性大鼠对 diazepam(0 - 3.0 mg/kg腹腔注射)和氯氮䓬(0 - 10 mg/kg腹腔注射)的反应。我们的结果表明,恐惧增强惊吓反应的表达不存在性别差异。发情周期也不影响恐惧增强惊吓反应。此外,用diazepam或氯氮䓬治疗后,雄性和雌性大鼠的恐惧增强惊吓反应没有差异。总之,当前研究表明,雄性和雌性大鼠在条件性恐惧反应和对苯二氮䓬类药物的反应性方面没有差异。结果进一步表明,在这个范式中,与条件性恐惧相关的过程不受性腺激素波动的影响。这些发现可能表明,女性中焦虑症患病率较高更可能是由于对既往经历的反应差异或其他易感因素的差异,而不是条件性恐惧本身的差异。